Doctors are left stunned after cancer ‘disappears’ for EVERY patient in drug trial – raising hopes treatment is ‘tip of the iceberg’ and can be used to help people fighting other forms of the disease
A womb cancer drug has shocked experts with how effective it is against colorectal tumours, after it seemingly cured every patient in a trial. The antibody therapy Dostarlimab, already approved for women in the UK, smashed expectations in a study at Memorial Sloan Kettering Cancer Center in New York. All 18 colorectal cancer patients involved …